In both cell lines, the analysis of SQSTM1/p62 immunostaining indicates a markedly increase in dots per cell with BAF.A1 treatment (Figure 1F,G), although this increase was lower in DM1 cells. The gene discussed is SQSTM1; the disease is myotonic dystrophy type 1.